Shionogi stock

4507 · TSE · JPY

Compare Shionogi
¥3,121.00Change from previous close: −1.73%Absolute change: −¥55.00

Close · November 20, 2026

Price history

+14.81% over the period

1 year: from ¥2,718.50 (November 20, 2025) to ¥3,121.00 (November 20, 2026), +14.81%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026¥3,121.00
October 30, 2026¥3,012.00
September 30, 2026¥2,870.50
August 31, 2026¥2,910.50
July 31, 2026¥2,908.50
June 30, 2026¥2,789.00
May 29, 2026¥3,000.00
April 30, 2026¥3,170.00
March 31, 2026¥3,469.00
February 27, 2026¥3,664.00
January 30, 2026¥3,174.00
December 30, 2025¥2,841.00
November 28, 2025¥2,680.50
November 20, 2025¥2,718.50

At a glance

  • The company

    Research, develop, manufacture and distribute pharmaceuticals, diagnostic reagents, medical devices and consumer healthcare products

  • Latest results

    Quarter to September 30, 2026 · EPS ¥25.66 (estimate ¥38.19)

TickerLandia's take on Shionogi

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low¥2,583.50
52-wk high¥3,758.00

−16.95% from the 52-week high

Analysts · 11 analysts

Average target¥3,386.36+8.50% vs. price

Buy 4 · Hold 7 · Sell 0 · Buy

TickerLandia Fingerprint: Shionogi

Compared with similar companies: high profitability, low risk, and strong momentum.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Shionogi is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), Shionogi's P/E today is 12.9, below the median of its last 10 fiscal years (15.3; between 9.62 and 22.5 from 2017 to 2026). Shionogi's P/E (trailing 12 months): 11.2, −66% against the median of a group of 11 similar companies (33.5).

P/E compared with its history

Compared with 11 similar companies

Shionogi's metrics compared with similar companies
MetricShionogiPosition in the groupBand
P/E (trailing 12 months)11.2Low
Forward P/E16.3Low
Operating margin31.6%Middle
ROE15.2%Middle
Debt/equity0.39Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Shionogi. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥187.07B

Latest quarter · Q3 2026

Net income

¥21.85B

Latest quarter · Q3 2026

Quarterly net margin

11.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
¥2.66T
P/E
11.2
EPS
¥278.40
Volume
2.99M
Daily trading
€53.1M
Dividend yield
2.50%

How Shionogi is changing

All results
  • Revenue grew 11.0% a year on average over the last 5 years

  • Operating margin fell from 37.3% to 32.2%

  • Profits turn into cash: free cash flow equal to 97% of net income

Returns

Shionogi returns with dividends

¥1,000 invested in Shionogi 5 years ago, on November 22, 2021, would be worth ¥1,335 today with dividends reinvested: +33.47% in total, +5.95% per year. On price alone it would be ¥1,158 (+15.84%).

PeriodShionogiNikkei 225¥1,000 becomes
1 month+4.78%−11.92%¥1,048
6 months+2.83%−4.80%¥1,028
Year to date+9.86%+12.11%¥1,099
1 year+17.69%+13.27%¥1,177
3 years+46.04%+69.03%¥1,460
5 years+33.47%+89.55%¥1,335
10 years+116.47%+211.70%¥2,165

Over the last 6 months it has done better than 34% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment

The chart in detail

Shionogi: technical analysis

Shionogi shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 14.8% below its all-time closing high (¥3,664.00, February 27, 2026).

Trend
No clear trend
RSI (14 sessions)
55
Between 30 and 70
vs 200-session average
+1.52%

Support and resistance

Price areas where Shionogi has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance¥3,225.33+3.34%3 touches, last on November 5, 2026
  2. Last price¥3,121.00
  3. Support¥3,089.00−1.03%3 touches, last on October 23, 2026
  4. Support¥3,014.50−3.41%3 touches, last on September 17, 2026
  5. Support¥2,944.00−5.67%4 touches, last on October 30, 2026

Volatility and risk

Over the last year it has moved little with the Nikkei 225.

Beta (1 year) vs Nikkei 225
0.08
Volatility (60 sessions, annualised)
30.3%
Largest fall in the last year
−27.37%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Shionogi: seasonality

Average monthly price change over 27 years

−2.9%Jan+1.6%Feb+0.8%Mar+0.2%Apr+1.9%May+1.1%Jun−1.2%Jul+0.1%Aug+2.1%Sep+1.1%Oct+3.0%Nov+2.8%Dec

Over the last 27 years, the strongest month for Shionogi has been November: +2.99% on average, positive in 17 years out of 26. The weakest has been January: −2.86% on average, positive in 10 years out of 26.

Show chart data
MonthAverageMedianPositive years
January−2.86%−4.30%10 of 26
February+1.55%+1.35%15 of 27
March+0.79%−1.35%13 of 27
April+0.24%−1.50%10 of 27
May+1.91%+2.40%17 of 27
June+1.12%−0.32%13 of 27
July−1.16%−1.85%11 of 27
August+0.09%+0.07%14 of 27
September+2.14%+4.19%19 of 27
October+1.05%+0.69%15 of 27
November+2.99%+3.86%17 of 26
December+2.83%+3.86%20 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Shionogi and its competitors

Shionogi & Co., Ltd. sells its pharmaceuticals, diagnostic reagents and medical devices in Japan and internationally. Its business covers research, development, manufacture and distribution of these products, alongside a consumer healthcare business. The company also develops mucosal vaccines, manufactures investigational drugs, and offers contract research and testing services for experimental research, agricultural production materials and pharmaceutical engineering, as well as IT and marketing support for healthcare customers.

Headquarters
Kita, Japan
Employees
6,223
Founded
1878
Chief executive
Isao Teshirogi
Shionogi and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Shionogi4507$16.75B31.6%11.2+2.83%
PharmaEssentia6446$15.94B38.4%74.1+54.65%
Yunnan Baiyao Group000538$15.07B11.2%19.4+11.07%
Torrent PharmaceuticalsTORNTPHARM$19.25B22.2%79.2+5.88%
Laurus LabsLAURUSLABS$14.13B24.1%97.8+68.58%
Zydus LifesciencesZYDUSLIFE$12.92B17.2%28.7+15.29%

Same industry or related industries, similar size. Compare Shionogi with its competitors · Full profile